What is the recommended treatment for trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Trichomoniasis

The preferred treatment for trichomoniasis is metronidazole 500 mg orally twice daily for 7 days, which achieves superior cure rates compared to single-dose therapy and should be used for all patients. 1, 2

First-Line Treatment Regimen

  • Metronidazole 500 mg orally twice daily for 7 days is the CDC-recommended preferred regimen, achieving cure rates of 90-95% 1, 2, 3
  • This multi-day regimen demonstrates significantly better efficacy than single-dose therapy, with an 8% absolute reduction in treatment failure (11% vs 19% failure rates) 4
  • The single 2g dose of metronidazole, while FDA-approved and historically used, is now considered an alternative rather than preferred option due to higher failure rates 5, 3

Critical Partner Management

  • All sexual partners must be treated simultaneously, regardless of symptoms or test results 1, 2, 6
  • Patients must abstain from all sexual activity until both partners complete the full treatment course and are completely asymptomatic 1, 2, 6
  • Failure to treat partners is the single most common cause of recurrent infection and apparent treatment failure 2

Special Population Considerations

Pregnancy

  • Metronidazole is contraindicated during the first trimester 1, 2
  • After the first trimester, use metronidazole 2g orally as a single dose (not the 7-day regimen, to minimize fetal exposure) 1, 2
  • Treatment is important as trichomoniasis increases risk of premature rupture of membranes and preterm delivery 1

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients (metronidazole 500 mg twice daily for 7 days) 1, 2, 6
  • No dose adjustment or alternative regimen is needed 1, 2

Treatment Failure Algorithm

When treatment fails despite documented adherence and partner treatment:

  1. First failure: Re-treat with metronidazole 500 mg twice daily for 7 days 1, 2, 6
  2. Second failure: Administer metronidazole 2g once daily for 3-5 days 1, 2, 6
  3. Persistent failure: Consult infectious disease specialist for possible resistance testing and desensitization protocols 1, 6

The MLC associated with metronidazole treatment failure is ≥50 μg/mL, and for tinidazole is ≥6.3 μg/mL 7

Alternative Agent: Tinidazole

  • Tinidazole 2g orally as a single dose is FDA-approved and achieves equivalent cure rates (95-97.5%) to metronidazole 8, 9
  • May be considered when adherence to multi-day regimens is problematic 6
  • Has similar side effect profile to metronidazole 9

Critical Pitfalls to Avoid

  • Never use topical metronidazole gel for trichomoniasis - it has <50% efficacy because it fails to achieve therapeutic levels in the urethra and perivaginal glands where the organism resides 2, 6
  • Counsel patients to avoid all alcohol during treatment and for at least 24 hours after completion due to disulfiram-like reaction causing nausea, vomiting, flushing, and abdominal cramps 6
  • Do not assume asymptomatic male partners are uninfected - they harbor the organism and must be treated to prevent reinfection 5, 3

Follow-Up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment 1, 2, 6
  • Re-evaluate only if symptoms persist, considering either reinfection from untreated partner or resistant infection 2, 6

References

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single dose treatment of trichomoniasis.

The Journal of international medical research, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.